Anti-collision systems in tunneling to improve effectiveness and safety in a system-quality approach: A review of the state of the art

Tunnelling and underground construction operations are often characterized by critical safety issues mainly due to poor visibility and blind spots around large vehicles and equipment. This can lead to collisions between vehicles or between vehicles and pedestrians or structural elements, causing accidents and fatalities. To improve the OS&H conditions, it is important to investigate the possible introduction of innovative techniques and technologies to reduce the occurrences and consequences of shared spaces (spaces used by both vehicles and pedestrians). For this reason, research was conducted to investigate the possible use of different technologies of anti-collision systems in tunnelling operations. First, to achieve this goal, an extensive review of the literature was carried out in accordance with the PRISMA statement to select the current techniques and technologies used by general anti-collision systems in civil and mining construction sites. Then, the operating principles, the relative advantages and disadvantages, combinations, and costs were examined for each of these. Eight types of systems and many examples of applications of anti-collision systems in underground environments were identified as a result of the analysis of the literature. Generally, it was noted that the anti-collision techniques available have found limited application in the excavation sites of underground civil works up to the present day, though the improvement in terms of safety and efficiency would be considerable

An open source physiologically based kinetic model for the chicken (Gallus gallus domesticus): Calibration and validation for the prediction residues in tissues and eggs.

Xenobiotics from anthropogenic and natural origin enter animal feed and human food as regulated compounds, environmental contaminants or as part of components of the diet. After dietary exposure, a chemical is absorbed and distributed systematically to a range of organs and tissues, metabolised, and excreted. Physiologically based kinetic (PBK) models have been developed to estimate internal concentrations from external doses. In this study, a generic multi-compartment PBK model was developed for chicken. The PBK model was implemented for seven compounds (with log Kow range −1.37–6.2) to quantitatively link external dose and internal dose for risk assessment of chemicals. Global sensitivity analysis was performed for a hydrophilic and a lipophilic compound to identify the most sensitive parameters in the PBK model. Model predictions were compared to measured data according to dataset-specific exposure scenarios. Globally, 71% of the model predictions were within a 3-fold change of the measured data for chicken and only 7% of the PBK predictions were outside a 10-fold change. While most model input parameters still rely on in vivo experiments, in vitro data were also used as model input to predict internal concentration of the coccidiostat monensin. Future developments of generic PBK models in chicken and other species of relevance to animal health risk assessment are discussed. Keywords: Risk assessment, Chicken, Physiologically based kinetic model, In vitro to in vivo extrapolation, Global sensitivity analysi

Chronic Endometritis in Subfertile Mares With Presence of Chlamydial DNA

When endometritis becomes chronic in mares, infertility can follow. Among various causative agents, many bacteria are involved, and mono- or mixed-infections are common. In our study, 50 mares with a previous history of subfertility were subjected to clinical and ultrasonographic examination of the reproductive tract, and samples were collected for cytology, histology, bacteriology, and polymerase chain reaction for Chlamydia spp detection. The aim of this work was to highlight the presence of Chlamydia abortus in chronic endometritis of subfertile mares. Endometrial chronic lesions were detected in five of six Chlamydia-positive animals

A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients

Forty-eight patients who provided 2 consecutive blood samples that tested positive for cytomegalovirus DNA by polymerase chain reaction (PCR) were randomized to receive either full-dose ganciclovir ( 5 mg/kg intravenously [iv] twice daily) or half-dose ganciclovir (5 mg/kg iv once daily) plus half-dose foscarnet (90 mg/kg iv once daily) for 14 days. In the ganciclovir arm, 17 (71%) of 24 patients reached the primary end point of being CMV negative by PCR within 14 days of initiation of therapy, compared with 12 (50%) of 24 patients in the ganciclovir-plus-foscarnet arm (P = .12). Toxicity was greater in the combination-therapy arm. In patients who failed to reach the primary end point, baseline virus load was 0.77 log(10) higher, the replication rate before therapy was faster (1.5 vs. 2.7 days), and the viral decay rate was slower (2.9 vs. 1.1 days) after therapy. Bivariable logistic regression models identified baseline virus load, bone-marrow transplantation, and doubling time and half-life of decay as the major factors affecting response to therapy within 14 days. This study did not support a synergistic effect of ganciclovir plus foscarnet in vivo